Table 1.
Lectin | Target | Cancer Type | Nanoparticles | Application | Reference |
---|---|---|---|---|---|
ConA | TF antigen | Bone cancer | DOX-loaded MSNs | Targeting Therapy |
[43] |
WGA | Neu5Ac GlcNac |
Colon adenocarcinoma | 5-FU-EGCG -gelatin-chitosan NPs | Targeting Therapy |
[44] |
UEA I | α-L-fucose | Colorectal cancer | Fluorescent MSNs | Targeting Diagnosis |
[45] |
ConA | TF antigen | Adenocarcinoma of the cervix | DOX-loaded graphene QDs -Fe3O4 | Targeting Therapy Diagnosis |
[46] |
JCA | TF antigen | Colorectal and breast adenocarcinoma | Phthalocyanine- PEG-AuNPs | Targeting Therapy |
[47] |
ConA; RCA; WGA | TF antigen; β-D-galactose; Neu5Ac and GlcNac |
Colorectal cancer | Fe2O3 -AuNPs | Targeting Diagnosis |
[48] |
Cramoll | glucose/mannose | Fibroadenoma and invasive ductal carcinoma human breast tissue | QDs | Targeting Diagnosis |
[49] |
ALL | LeX | Colon cancer | ATTO 430LS dye-loaded MSNs | Targeting Diagnosis Therapy |
[50] |
LTL | α-1,2-linked fucose | Prostate carcinoma and melanoma | DOX-loaded liposomes | Targeting Therapy |
[51] |